Muscle Structure, Function and Gait in dHMN (NCT04193228) | Clinical Trial Compass
CompletedNot Applicable
Muscle Structure, Function and Gait in dHMN
United Kingdom11 participantsStarted 2021-11-02
Plain-language summary
Distal Hereditary Motor Neuropathy (dHMN) is a rare inherited neuromuscular disorder. It is characterised by distal weakness. The condition usually manifests in the second decade of life and progresses slowly. Though patients usually have a normal lifespan it is a disabling condition and most eventually need aids to walk. In order to improve walking quality in patient with dHMN, research is needed to understand the impairments that lead to altered gait patterns, and to develop interventions to correct walking gait conservatively.
In this proposed trial our goal is to explore the relationships between muscle structure, function and gait patterns for people with Distal Hereditary Motor Neuropathy. Over 12 months, muscle changes in dHMN are going to be observed in terms of structure and function using MRI, myometry and 3D motion analysis. In addition, the effect of a 16 weeks exercises program on muscle structure and function in dHMN is going to be measured by the same observational methods. To address walking gait directly in dHMN, gait patterns with and without wearing carbon fibre ankle foot orthoses (AFO)will be measured using 3D motion analysis.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Adult patients aged 18 or above.
✓. Clinical and electrophysiological features of dHMN.
✓. Participant is able to give informed consent and has signed the informed consent form.
✓. Patients who are able to complete calf and thigh myometry and 3D gait analysis.
✓. Patients who have no contraindication to MRI scanning.
✓. Participant for objective 3, at least one of the major muscle groups of the ankle, dorsiflexors or plantarflexors, will score over 4/5 on the MRC scale.
✓. Adult aged 18 or above.
✓. Participants who have no known neuromuscular disease.
Exclusion criteria
✕. Known neuromuscular disorder other than dHMN.
✕. Lower limbs surgery planned during the study period or performed within the preceding 12 months.